Table 1 Comparison of the different guidelines available for acute GvHD assessment: individual organ severity staging

From: EBMT−NIH−CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment

Organ Severity Stage

Original Glucksberg criteria [13]

“Modified Glucksberg” or “Keystone” criteria [14] and IBMTR criteria [15]

MAGIC criteria [16]

Skin

   

0

No rash

No rash

No rash

1

Rash < 25% of BSA

Rash < 25% of BSA

Rash < 25% of BSA

2

Rash 25% to 50% of BSA

Rash 25% to 50% of BSA

Rash 25% to 50% of BSA

3

Rash > 50% of BSA

Rash > 50% of BSA

Rash > 50% of BSA

4

Generalized erythroderma with bullous formation

Generalized erythroderma with bullous formation

Generalized erythroderma ( > 50% BSA) plus bullous formation and desquamation >5% of BSA

Liver

   

0

Total serum bilirubin < 34 µmol/L ( < 2 mg/dL) or AST/SGOT 150-750 IU

Total serum bilirubin < 34 µmol/L ( < 2 mg/dL)

Total serum bilirubin < 34 µmol/L ( < 2 mg/dL)

1

Total serum bilirubin 34-50 µmol/L (2 to 3 mg/dL)

Total serum bilirubin 34-50 µmol/L (2 to 3 mg/dL)

Total serum bilirubin 34-50 µmol/L (2 to 3 mg/dL)

2

Total serum bilirubin 51-102 µmol/L (3.1 to 6 mg/dL)

Total serum bilirubin 51-102 µmol/L (3.1 to 6 mg/dL)

Total serum bilirubin 51-102 µmol/L (3.1 to 6 mg/dL)

3

Total serum bilirubin 103-255 µmol/L (6.1 to 15 mg/dL)

Total serum bilirubin 103-255 µmol/L (6.1 to 15 mg/dL)

Total serum bilirubin 103-255 µmol/L (6.1 to 15 mg/dL)

4

Total serum bilirubin > 255 µmol/L ( > 15 mg/dL)

Total serum bilirubin > 255 µmol/L ( > 15 mg/dL)

Total serum bilirubin > 255 µmol/L ( > 15 mg/dL)

Upper GI

   

0

NA

No persistent nausea and no histologic evidence of GvHD in the stomach or duodenum

No or intermittenta anorexia or nausea or vomiting

1

NA

Persistent nausea with histologic evidence of GvHD in the stomach or duodenum

Persistenta anorexia or nausea or vomiting

Lower GI

   

0

Diarrhea < 500 mL/day

Diarrhea < 500 mL/day

Diarrhea < 500 mL/day or < 3 episodes/day for adultsb,c

1

Diarrhea > 500 mL/day

Diarrhea > 500 mL/day

Diarrhea 500-999 mL/day or 3-4 episodes/day for adultsb,d

2

Diarrhea > 1000 mL/day

Diarrhea > 1000 mL/day

Diarrhea 1000-1500 mL/day or 5-7 episodes/day for adultsb,e

3

Diarrhea > 1500 mL/day

Diarrhea > 1500 mL/day

Diarrhea >1500 mL/day or >7 episodes/day for adultsb,f

4

Diarrhea >2000 mL/day

Severe abdominal pain with or without ileus

Severe abdominal pain with or without ileus or grossly bloody stools (regardless of stool volume)

Karnofsky index

   
 

>30%

NA

NA

 

<30%

NA

NA

  1. AST (Aspartate transaminase); BSA (Body surface area); GI (Gastro-intestinal tract); GvHD (Graft versus Host Disease); IBMTR (International Bone Marrow Transplantation Registry); IU (International units); MAGIC (Mount Sinai Acute GvHD International Consortium); NA (Not applicable); SGOT (Serum glutamic oxaloacetic acid transaminase)
  2. aTo be suggestive for GvHD: anorexia should be accompanied by weight loss, nausea should last at least 3 days, or be accompanied by at least 2 vomiting episodes per day for at least 2 days [16]
  3. bOne episode of diarrhea is considered to be about 200 ml for an adult and 3 ml/kg for a child ( < 50 kg) [16]
  4. cDiarrhea <10 mL/kg/day or <4 episodes/day for children
  5. dDiarrhea 10-19.9 mL/kg/day or 4-6 episodes/day for children
  6. eDiarrhea 20-30 mL/kg/day or 7-10 episodes/day for children
  7. fDiarrhea > 30 mL/kg/day or >10 episodes/day for children